Dokumen

Perbincangan Teknikal Ramalan Bermusim Opsyen

Pemfailan SEC dan dokumen lain TELA Bio, Inc.

Terokai dokumen syarikat terkini dan pemfailan SEC dari TELA Bio, Inc., termasuk Forms 10-K, 10-Q, 8-K dan pendedahan utama lain. Nilaikan prestasi kewangan dan kemas kini pengoperasian untuk melakukan keputusan lebih termaklum.

Rakan kongsi data

Huraian

Reported date

Borang

2025

Canaccord Genuity’s 45th Annual Growth Conference

Ogos 13, 2025

Transcript

Q2 2025

Ogos 11, 2025

Transcript

Quarterly report10-Q

Earnings release8-K

Investor Presentation

Ogos 10, 2025

Slides

Q1 2025

Mei 08, 2025

Transcript

Quarterly report10-Q

Earnings release8-K

2024

Q4 2024

Mac 20, 2025

Transcript

Annual report10-K

Earnings release8-K

Q3 2024

Nov 07, 2024

Quarterly report10-Q

Earnings release8-K

Q2 2024

Ogos 12, 2024

Quarterly report10-Q

Earnings release8-K

Q1 2024

Mei 09, 2024

Quarterly report10-Q

Earnings release8-K

2023

Q4 2023

Mac 21, 2024

Annual report10-K

Earnings release8-K

Q3 2023

Nov 09, 2023

Quarterly report10-Q

Earnings release8-K

Q2 2023

Ogos 09, 2023

Quarterly report10-Q

Earnings release8-K

Q1 2023

Mei 11, 2023

Quarterly report10-Q

Earnings release8-K

JPMorgan Healthcare Conference

Jan 12, 2023

Slides

2022

Q4 2022

Mac 21, 2023

Annual report10-K

Earnings release8-K

Q3 2022

Nov 09, 2022

Quarterly report10-Q

Earnings release8-K

Q2 2022

Ogos 10, 2022

Quarterly report10-Q

Earnings release8-K

2021

Q4 2021

Mac 23, 2022

Annual report10-K

2020

Q4 2020

Mac 25, 2021

Annual report10-K

2019

Q4 2019

Mac 30, 2020

Annual report10-K